Literature DB >> 3597772

Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo.

K R Feingold, C Grunfeld.   

Abstract

The hyperlipidemia accompanying infection has been attributed to production of tumor necrosis factor. This cytokine inhibits adipose tissue lipoprotein lipase, which could decrease clearance of lipoproteins. Infections also increase hepatic lipogenesis. We now have demonstrated that tumor necrosis factor-alpha stimulates lipid synthesis in vivo. 2 h after administration of tumor necrosis factor (25 micrograms/200 g), plasma triglycerides increase 2.2-fold and remain elevated for 17 h. Plasma cholesterol also increases, but this effect appears after 7 h. Tumor necrosis factor rapidly stimulates incorporation of tritiated water into fatty acids in the liver (1-2 h), which persists for 17 h. Also, tumor necrosis factor stimulates hepatic sterol synthesis. Of note, tumor necrosis factor treatment does not stimulate lipid synthesis in other tissues, including adipose tissue. Labeled fatty acids rapidly increase in the plasma, raising the possibility that stimulation of hepatic lipogenesis by tumor necrosis factor contributes to the hyperlipidemia of infection.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3597772      PMCID: PMC442217          DOI: 10.1172/JCI113046

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

Review 1.  Metabolic response to infection.

Authors:  W R Beisel
Journal:  Annu Rev Med       Date:  1975       Impact factor: 13.739

Review 2.  Reversible modulation of liver hydroxymethylglutaryl CoA reductase.

Authors:  D M Gibson; T S Ingebritsen
Journal:  Life Sci       Date:  1978-12-31       Impact factor: 5.037

3.  Serum lipids in infection.

Authors:  J I Gallin; D Kaye; W M O'Leary
Journal:  N Engl J Med       Date:  1969-11-13       Impact factor: 91.245

4.  Selective inhibition of synthesis of enzymes for de novo fatty acid biosynthesis by an endotoxin-induced mediator from exudate cells.

Authors:  P H Pekala; M Kawakami; C W Angus; M D Lane; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

Review 5.  Regulation of liver 3-hydroxy-3-methylglutaryl-CoA reductase.

Authors:  Z H Beg; H B Brewer
Journal:  Curr Top Cell Regul       Date:  1981

6.  Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin.

Authors:  D Pennica; G E Nedwin; J S Hayflick; P H Seeburg; R Derynck; M A Palladino; W J Kohr; B B Aggarwal; D V Goeddel
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

7.  Hypertriglyceridemia produced by endotoxin: role of impaired triglyceride disposal mechanisms.

Authors:  R L Kaufmann; C F Matson; W R Beisel
Journal:  J Infect Dis       Date:  1976-05       Impact factor: 5.226

8.  The effect of diabetes mellitus on sterol synthesis in the intact rat.

Authors:  K R Feingold; M H Wiley; G MacRae; A H Moser; S R Lear; M D Siperstein
Journal:  Diabetes       Date:  1982-05       Impact factor: 9.461

9.  De novo sterologenesis in the intact rat.

Authors:  K R Feingold; M H Wiley; G MacRae; S Lear; A H Moser; G Zsigmond; M D Siperstein
Journal:  Metabolism       Date:  1983-01       Impact factor: 8.694

10.  Lipoprotein lipase suppression in 3T3-L1 cells by an endotoxin-induced mediator from exudate cells.

Authors:  M Kawakami; P H Pekala; M D Lane; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

View more
  89 in total

Review 1.  Mechanisms and cell signaling in alcoholic liver disease.

Authors:  Juliane I Beier; Craig J McClain
Journal:  Biol Chem       Date:  2010-11       Impact factor: 3.915

2.  Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice.

Authors:  L C Wood; S M Jackson; P M Elias; C Grunfeld; K R Feingold
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

3.  Effect of tumor necrosis factor (TNF) on lipid metabolism in the diabetic rat. Evidence that inhibition of adipose tissue lipoprotein lipase activity is not required for TNF-induced hyperlipidemia.

Authors:  K R Feingold; M Soued; I Staprans; L A Gavin; M E Donahue; B J Huang; A H Moser; R Gulli; C Grunfeld
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

4.  Effect of tumor necrosis factor-alpha on triglyceride and phospholipid content and fatty acid composition of liver and carcass in rats.

Authors:  N Raina; J Matsui; S C Cunnane; K N Jeejeebhoy
Journal:  Lipids       Date:  1995-08       Impact factor: 1.880

5.  Metabolic effects of tumour necrosis factor-alpha on rat brown adipose tissue.

Authors:  J López-Soriano; J M Argilés; F J López-Soriano
Journal:  Mol Cell Biochem       Date:  1995-02-23       Impact factor: 3.396

6.  Decreased cholesteryl ester transfer protein (CETP) mRNA and protein and increased high density lipoprotein following lipopolysaccharide administration in human CETP transgenic mice.

Authors:  L Masucci-Magoulas; P Moulin; X C Jiang; H Richardson; A Walsh; J L Breslow; A Tall
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

7.  Ca2+ responses to interleukin 1 and tumor necrosis factor in cultured human skin fibroblasts. Possible implications for Reye syndrome.

Authors:  B E Corkey; J F Geschwind; J T Deeney; D E Hale; S D Douglas; L Kilpatrick
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

8.  Contribution of increased HMG-CoA reductase gene expression to hypercholesterolemia in experimental chronic renal failure.

Authors:  Michal Chmielewski; Elzbieta Sucajtys; Julian Swierczynski; Boleslaw Rutkowski; Wojciech Bogusławski
Journal:  Mol Cell Biochem       Date:  2003-04       Impact factor: 3.396

Review 9.  Are cytokines possible mediators of cancer cachexia?

Authors:  Y Noguchi; T Yoshikawa; A Matsumoto; G Svaninger; J Gelin
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

10.  The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans.

Authors:  Y M Fong; M A Marano; L L Moldawer; H Wei; S E Calvano; J S Kenney; A C Allison; A Cerami; G T Shires; S F Lowry
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.